Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica Colombo

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
British Journal of Haematology|September 12, 2014
Is ZAP70 still a key prognostic factor in early stage chronic lymphocytic leukaemia? Results of the analysis from a prospective multicentre observational studyFortunato Morabito, Giovanna Cutrona, Massimo Gentile, et al.
Plos One|March 19, 2015
Insulin growth factor 1 receptor expression is associated with NOTCH1 mutation, trisomy 12 and aggressive clinical course in chronic lymphocytic leukaemiaFrancesco Maura, Laura Mosca, Sonia Fabris, et al.
Non-Coding RNA|September 23, 2024
MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective StudyEnnio Nano, Francesco Reggiani, Adriana Agnese Amaro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2014
microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parametersMassimo Negrini, Giovanna Cutrona, Cristian Bassi, et al.
Leukemia & Lymphoma|April 11, 2015
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemiaFrancesco Maura, Giovanna Cutrona, Laura Mosca, et al.
Frontiers in Oncology|August 19, 2021
Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic LeukemiaFortunato Morabito, Giovanni Tripepi, Riccardo Moia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2013
Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical featuresFortunato Morabito, Laura Mosca, Giovanna Cutrona, et al.
Blood Advances|July 12, 2022
MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cellsSerena Matis, Anna Grazia Recchia, Monica Colombo, et al.
American Journal of Hematology|October 10, 2012
Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemiaSonia Fabris, Laura Mosca, Giovanna Cutrona, et al.
Science Translational Medicine|February 16, 2018
Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolenceGiovanna Cutrona, Claudio Tripodo, Serena Matis, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
British Journal of Haematology|September 12, 2014
Is ZAP70 still a key prognostic factor in early stage chronic lymphocytic leukaemia? Results of the analysis from a prospective multicentre observational studyFortunato Morabito, Giovanna Cutrona, Massimo Gentile, et al.
Plos One|March 19, 2015
Insulin growth factor 1 receptor expression is associated with NOTCH1 mutation, trisomy 12 and aggressive clinical course in chronic lymphocytic leukaemiaFrancesco Maura, Laura Mosca, Sonia Fabris, et al.
Non-Coding RNA|September 23, 2024
MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective StudyEnnio Nano, Francesco Reggiani, Adriana Agnese Amaro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2014
microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parametersMassimo Negrini, Giovanna Cutrona, Cristian Bassi, et al.
Leukemia & Lymphoma|April 11, 2015
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemiaFrancesco Maura, Giovanna Cutrona, Laura Mosca, et al.
Frontiers in Oncology|August 19, 2021
Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic LeukemiaFortunato Morabito, Giovanni Tripepi, Riccardo Moia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2013
Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical featuresFortunato Morabito, Laura Mosca, Giovanna Cutrona, et al.
Blood Advances|July 12, 2022
MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cellsSerena Matis, Anna Grazia Recchia, Monica Colombo, et al.
American Journal of Hematology|October 10, 2012
Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemiaSonia Fabris, Laura Mosca, Giovanna Cutrona, et al.
Science Translational Medicine|February 16, 2018
Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolenceGiovanna Cutrona, Claudio Tripodo, Serena Matis, et al.
Pageof 8